Daan Dierickx

机构：KU Leuven · ORCID：0000-0002-8917-022X

发表论文 331 篇 · 总被引 9005 次 · h-index 45

代表论文

• Treatment of Epstein-Barr Virus infection in immunocompromised patients (2024 · Biochemical Pharmacology · 被引 23)
• Lymphoma Classifications, How to Develop a Future Unified Taxonomy (2024 · Journal of Clinical Oncology · 被引 14)
• Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies (2024 · European Journal of Cancer · 被引 12)
• Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders (2024 · Cell Reports Medicine · 被引 9)
• International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume-Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma. (2024 · PubMed · 被引 5)
• Viral Infections in HSCT Recipients with Post-Transplant Lymphoproliferative Disorder: The Role of Torque Teno Virus as a Marker of Immune Functions (2025 · Microorganisms · 被引 3)